Trials / Active Not Recruiting
Active Not RecruitingNCT04874558
Ultra-low-dose Chest CT for HHT
Novel Ultra-low-dose Chest CT Technique to Screen for Pulmonary Arteriovenous Malformations in Pediatric Patients With Hereditary Hemorrhagic Teleangiectasia
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 1 Year – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to develop a novel ultra-low dose chest CT technology for use in Hereditary Hemorrhagic Teleangiectasia (HHT) patients and to determine the lowest possible radiation dose that is achievable without sacrificing the diagnostic quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Ultra-low dose chest CT | A novel CT technique with a new dose optimization and efficiency technology and automatic kV selection, which greatly reduces the dose of radiation exposure compared to a standard chest CT. |
Timeline
- Start date
- 2021-04-21
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2021-05-05
- Last updated
- 2025-07-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04874558. Inclusion in this directory is not an endorsement.